(Total Views: 588)
Posted On: 12/08/2023 11:54:37 AM
Post# of 148878
I am also looking forward to news from Dr. Jay regarding the following:
CytoDyn Announces Preliminary Results from 30 mTNBC Patients Treated with Leronlimab. Decreases in CAMLs after 4 Doses of Leronlimab were Identified in Over 70% of Patients and were Associated with a 450% Significant Increase in Overall Survival at 12-Month Analysis.
This is from
Mon, Jul 19, 2021, 3:00 AM
Cheers
CytoDyn Announces Preliminary Results from 30 mTNBC Patients Treated with Leronlimab. Decreases in CAMLs after 4 Doses of Leronlimab were Identified in Over 70% of Patients and were Associated with a 450% Significant Increase in Overall Survival at 12-Month Analysis.
This is from
Mon, Jul 19, 2021, 3:00 AM
Cheers
(4)
(0)Scroll down for more posts ▼
